Latest News

Date Title Topic
28 Apr 2016 Register today for ESMO 2016
IT and Digital Services Department Manager
25 Apr 2016 Integrating Patients’ Views in Clinical Studies of Anticancer Medicines Anticancer agents & Biologic therapy
22 Apr 2016 Genetic Alterations in Cutaneous Melanoma – what do we know? Melanoma
ESMO Preceptorship Meetings Coordinator
Soft Tissue Sarcomas
19 Apr 2016 April 2016 - Image of the Month
19 Apr 2016 Microbiota in Colorectal Cancer Basic science - Gastrointestinal cancers
18 Apr 2016 FDA Approves Venetoclax for CLL in Patients With 17p Deletion Who Have Been Treated With at Least One Prior Therapy Personalised medicine - Haematologic malignancies - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Osimertinib Combined With Durvalumab in EGFR-mutant Non-Small-Cell Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Updates from CheckMate 063 and 017 Trials Confirm Nivolumab Efficacy in Patients with Advanced Platinum-Refractory Squamous NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
15 Apr 2016 ELCC 2016 News: Novel Durvalumab plus Gefitinitib Shows Promise in EGFR Mutated NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Comprehensive Molecular Profiling Shows Disparity Between Primary NSCLC Tumours and Metastases Pathology/Molecular biology - Lung and other thoracic tumours
15 Apr 2016 ELCC 2016 Press Release: Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy Lung and other thoracic tumours - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 Press Release: Studies Confirm Benefit of Plasma Genotyping to Predict Treatment Benefit in Patients with Non-Small-Cell Lung Cancer Lung and other thoracic tumours